Stockreport

CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com
PDF - Phase 1 clinical study of CX-2051, an EpCAM targeting PROBODY ® ADC, is ongoing. Study is currently enrolling third cohort with enrollment focused primarily in colore [Read more]